Skip to main content

Table 3 Summary data from 73 dogs with metastatic hemangiosarcoma

From: Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study

 

Surgery alone

(n = 42)

Surgery plus chemotherapy

(n = 23)

Surgery plus autologous cancer vaccine

(n = 8)

Age, years (mean ± SD)

10.3 ± 2.00

10.0 ± 2.21

7.6 ± 1.71

Weight, kg (mean ± SD)

30.2 ± 5.96

31.6 ± 9.84

39.5 ± 11.83

Adverse events (%)

0

43

0

Hopitalizations (%)

0

17

0

Median survival time, days

41

142

142

Survival range, days

2 to 145

26 to 241

61 to 373

Alive at 1 year (%)

0

0

12.5